0 التعليقات
0 المشاركات
2كيلو بايت مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 التعليقات 0 المشاركات 656 مشاهدة 0 معاينة
-
HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-UserHER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...0 التعليقات 0 المشاركات 638 مشاهدة 0 معاينة
-
What Is the Market Outlook for Biosimilars in the Anticancer Drug Segment?Anticancer Drugs Market Poised for Robust Growth Through 2030 The global anticancer drugs market is experiencing significant expansion, with projections estimating an increase from USD 222.57 billion in 2023 to USD 495.07 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 12.1% during the forecast period. Curious to peek inside? Grab your sample copy of...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة